ArticleCancer immunology research2019

ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome.

Claire Y Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.